InBrain Pharma to present long-term DIVE-I data at MDS 2025

InBrain Pharma will present long-term follow-up data from its Phase I/II DIVE-I study at the International Conference of Parkinson’s Disease and Movement Disorders (MDS) 2025, to be held October 5–9 in Honolulu, Hawaii, the company said. The oral presentation is scheduled for October 8 at 12:00 pm (…